3349 コスモス薬品

累計 / 通期：4Q / 3Q / 2Q / 1Q

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/05	3Q	810,380	32,021	4.0%	33,865	4.2%	22,748	2.8%	287.02	7.7%	1.2%	0.3%	1.8%
2025/05	3Q	752,268	31,627	4.2%	33,771	4.5%	22,343	3.0%	281.91	5.2%	33.2%	30.3%	28.7%
2024/05	3Q	715,311	23,738	3.3%	25,914	3.6%	17,357	2.4%	438.14	18.0%	7.1%	6.2%	6.6%
2023/05	3Q	606,302	22,167	3.7%	24,393	4.0%	16,283	2.7%	411.22	8.5%	1.2%	1.2%	-1.0%
2022/05	3Q	558,885	21,897	3.9%	24,100	4.3%	16,455	2.9%	415.56	3.2%	-15.8%	-13.5%	-23.8%
2021/05	3Q	541,697	26,010	4.8%	27,859	5.1%	21,581	4.0%	545.00	9.9%	33.8%	31.4%	51.6%
2020/05	3Q	492,877	19,434	3.9%	21,201	4.3%	14,239	2.9%	719.17	9.4%	7.8%	7.7%	7.8%
2019/05	3Q	450,487	18,025	4.0%	19,686	4.4%	13,207	2.9%	667.09	-	-	-	-

決算期	四半期	売上高	営業利益	営業利益率	経常利益	経常利益率	純利益	純利益率	EPS	売上高前年比	営業利益前年比	経常利益前年比	純利益前年比
2026/05	3Q	58,112	394	0.7%	94	0.2%	405	0.7%	5.11	57.2%	-95.0%	-98.8%	-91.9%
2025/05	3Q	36,957	7,889	21.3%	7,857	21.3%	4,986	13.5%	-156.23	-66.1%	402.2%	416.6%	364.2%
2024/05	3Q	109,009	1,571	1.4%	1,521	1.4%	1,074	1.0%	26.92	129.9%	481.9%	419.1%	黒転
2023/05	3Q	47,417	270	0.6%	293	0.6%	-172	-0.4%	-4.34	175.9%	黒転	黒転	赤縮
2022/05	3Q	17,188	-4,113	-23.9%	-3,759	-21.9%	-5,126	-29.8%	-129.44	-64.8%	赤転	赤転	赤転
2021/05	3Q	48,820	6,576	13.5%	6,658	13.6%	7,342	15.0%	-174.17	15.2%	366.7%	339.5%	611.4%
2020/05	3Q	42,390	1,409	3.3%	1,515	3.6%	1,032	2.4%	52.08	-90.6%	-92.2%	-92.3%	-92.2%
2019/05	3Q	450,487	18,025	4.0%	19,686	4.4%	13,207	2.9%	667.09	-	-	-	-